DOPATREE
Preview
Open in TheBrain
DOPATREE
DRUGS AND BIOLOGICS / RELATED / US
DRUG SAFETY AND BIOLOGIC SAFETY (PHARMACOVIGILANCE, PV, CLINICAL, POSTMARKETING, SERIOUS ADVERSE EVENT, SAE, IND, 7-DAY, 15-DAY, EXPEDITED, SIDE EFFECTS, ICSR, PSUR, LITERATURE, SURVEILLANCE, E2B, SAFETY REPORTING, DATA, MEDICATION)
DRUG SAFETY AND BIOLOGIC SAFETY / RELATED / INTL
TREATMENT-RELATED CONDITIONS-ALL (DRUG-RELATED, BIOLOGIC-RELATED, DEVICE-RELATED, TREATMENT EMERGENT ADVERSE EVENTS, TEAE, ADVERSE DRUG REACTIONS, SIDE EFFECTS, ALL TOXICITIES, TOXICITY, PRODUCT-RELATED, DRUG-INDUCED)
TREATMENT-RELATED CONDITIONS / LISTINGS
PARASITIC INFECTIONS-ALL (PARASITES)
PARASITIC INFECTIONS / LISTINGS A-M
DIROFILARIASIS (DIROFILARIA IMMITIS, D. IMMITIS, DOG HEARTWORM, PULMONARY)
DIROFILARIASIS / LAWS AND REGULATIONS / US
Parents
DIROFILARIASIS (DIROFILARIA IMMITIS, D. IMMITIS, DOG HEARTWORM, PULMONARY)
Children
US FDA. DRAFT GUIDANCE. EFFECTIVENESS OF ANTHELMINTICS : SPECIFIC RECOMMENDATIONS FOR THE PREVENTION OF HEARTWORM DISEASE IN DOGS. #276. NOV 2022.